Hebei Weimiao Biology Co., LTD 1
Location
  • Home
  • tadalafil cas 171596-29-5

Dec . 03, 2024 10:38 Back to list

tadalafil cas 171596-29-5



Tadalafil An Overview of a Revolutionary Medicinal Compound


Tadalafil, identified by its chemical abstract service (CAS) number 171596-29-5, is a potent pharmaceutical compound that has revolutionized the treatment of erectile dysfunction (ED) and pulmonary arterial hypertension (PAH). First introduced into the market in 2003 under the brand name Cialis, tadalafil belongs to a class of drugs known as phosphodiesterase type 5 (PDE5) inhibitors. Its unique mechanism of action, along with a favorable pharmacokinetic profile, has made it a preferred choice for both patients and healthcare providers.


Mechanism of Action


The primary action of tadalafil involves the inhibition of the PDE5 enzyme, which is responsible for the degradation of cyclic guanosine monophosphate (cGMP) in the corpus cavernosum of the penis. During sexual arousal, nitric oxide (NO) is released, leading to increased levels of cGMP, which in turn causes smooth muscle relaxation and increased blood flow to the penis, facilitating an erection. By inhibiting PDE5, tadalafil ensures that cGMP levels remain elevated for a longer duration, thereby enhancing erectile function.


Unlike some of its counterparts, tadalafil has a long half-life of approximately 17.5 hours, which provides a distinctive advantage. This extended duration of action allows for greater spontaneity in sexual activity, as it can be effective for up to 36 hours after administration. This has led to colloquial references to tadalafil as the “weekend pill.”


Tadalafil An Overview of a Revolutionary Medicinal Compound

While tadalafil is predominantly recognized for its effectiveness in treating ED, it has also been approved for the treatment of PAH. In this context, tadalafil works by dilating the blood vessels in the lungs, reducing the overall workload on the heart and improving exercise capacity for individuals suffering from this condition. The dual application of tadalafil for both sexual dysfunction and severe pulmonary conditions highlights its versatility and importance in modern medicine.


tadalafil cas 171596-29-5

tadalafil cas 171596-29-5

Dosage and Administration


Tadalafil is available in various dosages, notably 2.5 mg, 5 mg, 10 mg, and 20 mg tablets. It can be prescribed for as-needed use or as a daily medication, depending on the severity of the condition and the patient’s lifestyle. Healthcare providers typically recommend starting with a lower dose, which can be increased based on efficacy and tolerability.


It is essential for patients to communicate openly with their healthcare providers about their health conditions and any medications they may be taking. This is particularly important as tadalafil can have interactions with nitrates and other drugs, leading to a potential risk of hypotension.


Side Effects and Considerations


While tadalafil is generally well-tolerated, like all medications, it may come with side effects. Common adverse effects include headaches, indigestion, back pain, muscle aches, flushing, and nasal congestion. Most side effects are mild to moderate in severity and often resolve on their own. However, patients should seek immediate medical attention if they experience severe side effects such as sudden vision loss, hearing loss, or an erection lasting longer than four hours (priapism).


Conclusion


Tadalafil stands as a testament to the advancements in pharmacology and the ongoing efforts to enhance the quality of life for patients suffering from erectile dysfunction and pulmonary arterial hypertension. With its effective mechanism of action, extended duration of effect, and widespread acceptance within the medical community, tadalafil continues to play a critical role in modern therapeutic practices. As research into sexual health and cardiovascular conditions evolves, tadalafil’s legacy as a leading PDE5 inhibitor remains secure, bringing hope and relief to millions worldwide.


Share
Next：

Latest news

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.


Hit enter to search or ESC to close
en_USEnglish
afAfrikaans sqAlbanian amAmharic arArabic hyArmenian azAzerbaijani euBasque belBelarusian bn_BDBengali bs_BABosnian bg_BGBulgarian caCatalan cebCebuano zh_CNChina zh_TWChina (Taiwan) coCorsican hrCroatian cs_CZCzech da_DKDanish nl_NLDutch eoEsperanto etEstonian fiFinnish fr_FRFrench fyFrisian gl_ESGalician ka_GEGeorgian de_DEGerman elGreek guGujarati htHaitian Creole haHausa hawHawaiian he_ILHebrew hi_INHindi hmnMiao hu_HUHungarian is_ISIcelandic igIgbo id_IDIndonesian gaIrish it_ITItalian jaJapanese jvJavanese knKannada kkKazakh kmKhmer rwRwandese ko_KRKorean ckbKurdish kyKyrgyz loLao laLatin lvLatvian lt_LTLithuanian lbLuxembourgish mk_MKMacedonian mgMalgashi ms_MYMalay ml_INMalayalam mtMaltese miMaori mrMarathi mnMongolian my_MMMyanmar ne_NPNepali nb_NONorwegian nyNorwegian orOccitan psPashto fa_IRPersian pl_PLPolish pt_PTPortuguese pa_INPunjabi ro_RORomanian ru_RURussian smSamoan gdScottish Gaelic sr_RSSerbian stSesotho snShona sdSindhi si_LKSinhala sk_SKSlovak sl_SISlovenian soSomali es_ESSpanish suSundanese swSwahili sv_SESwedish tlTagalog tgTajik ta_INTamil tt_RUTatar teTelugu thThai tr_TRTurkish tkTurkmen ukUkrainian urUrdu ug_CNUighur uz_UZUzbek viVietnamese cyWelsh xhBantu yiYiddish yoYoruba zuZulu en_USEnglish